Production (Stage)
Esperion Therapeutics, Inc.
ESPR
$1.17
-$0.03-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.81% | 0.03% | -23.55% | -16.46% | 175.52% |
| Total Receivables | 1.44% | 18.16% | 12.37% | 10.53% | 12.62% |
| Inventory | 5.11% | 17.96% | -5.17% | 15.56% | 11.39% |
| Prepaid Expenses | 26.47% | 24.76% | 35.87% | -2.79% | 140.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.69% | 9.90% | -10.88% | -5.61% | 81.83% |
|
|
|||||
| Total Current Assets | -5.69% | 9.90% | -10.88% | -5.61% | 81.83% |
| Net Property, Plant & Equipment | -9.92% | -11.32% | -9.11% | -3.28% | 58.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.76% | 9.46% | -10.84% | -5.56% | 81.28% |
|
|
|||||
| Total Accounts Payable | 39.39% | 48.15% | -26.86% | 67.65% | -10.36% |
| Total Accrued Expenses | -3.78% | 8.05% | -14.67% | 2.01% | -7.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.37% | 155.02% | 16.09% | -23.01% | 26.51% |
| Total Finance Division Other Current Liabilities | -6.93% | -3.02% | 2.38% | 2.59% | 7.01% |
| Total Other Current Liabilities | -6.93% | -3.02% | 2.38% | 2.59% | 7.01% |
| Total Current Liabilities | 10.04% | 48.45% | -5.40% | 6.58% | 5.31% |
|
|
|||||
| Total Current Liabilities | 10.04% | 48.45% | -5.40% | 6.58% | 5.31% |
| Long-Term Debt | -1.33% | -6.10% | -0.40% | 3.77% | -0.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.27% | -22.10% | -17.13% | -9.85% | 46.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.42% | 7.05% | -1.75% | 4.37% | 0.99% |
|
|
|||||
| Common Stock & APIC | 0.23% | 0.22% | 0.28% | 0.96% | 8.67% |
| Retained Earnings | -2.53% | -1.35% | -1.90% | -4.16% | 3.94% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -9.64% | -5.00% | -7.55% | -16.96% | 35.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.64% | -5.00% | -7.55% | -16.96% | 35.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.64% | -5.00% | -7.55% | -16.96% | 35.32% |
|
|
|||||